Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?
- PMID: 18398093
- DOI: 10.1093/jnci/djn098
Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?
Comment on
-
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.J Natl Cancer Inst. 2008 Apr 16;100(8):552-62. doi: 10.1093/jnci/djn089. Epub 2008 Apr 8. J Natl Cancer Inst. 2008. PMID: 18398094 Clinical Trial.
-
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.J Natl Cancer Inst. 2008 Apr 16;100(8):542-51. doi: 10.1093/jnci/djn085. Epub 2008 Apr 8. J Natl Cancer Inst. 2008. PMID: 18398097 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources